Roche Gives Up On Bid To Patent Cancer Fusion Gene Tool
European officials have revoked Roche's patent over a process for detecting hybrid genes associated with certain cancers after the pharmaceutical giant said it "no longer approved" of the text, handing an...To view the full article, register now.
Already a subscriber? Click here to view full article